饲喂不同浓度黄曲霉毒素B1饲料对花鳗鲡幼鱼生长、抗氧化能力和毒素积累的影响

以含不同浓度黄曲霉毒素B₁(AFB₁)(0、10、100和1000μg/kg饲料)的4种饲料饲喂平均初始体重为(6.41±0.10) g的花鳗鲡(Anguilla marmorata)幼鱼56d,探讨AFB₁对花鳗鲡幼鱼生长性能、抗氧化能力、肝脏组织结构及鱼体肌肉中的毒素积累的影响。结果表明,各实验组幼鱼均未表现出行为及体色的异常。1000μg/kg毒素组幼鱼的存活率、终末体重、摄食率、特定生长率和饲料效率显著低于对照组, 10μg/kg毒素组和100μg/kg毒素组与对照组无显著差异。10μg/kg毒素组幼鱼肝脏超氧化物歧化酶(SOD)、过氧化氢酶(CAT)、谷胱甘肽过氧化物酶(GSH-Px)、谷胱甘肽S转移酶(GST)活性和丙二醛(MDA)含量与对照组无显著差异。饲料AFB₁含量≥100μg/kg显著影响花鳗鲡幼鱼肝脏的超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSHPx)和谷胱甘肽转移酶(GST)活性。对照组和10μg/kg毒素组幼鱼肝脏组织学观察未发现明显病理变化。1000μg/kg毒素...     

饲料中添加溶菌酶对吉富罗非鱼生长、免疫-抗氧化功能及血清抗菌性能的影响

为研究在饲料中添加不同水平的溶菌酶制品对吉富罗非鱼(GIFT, Oreochromis niloticus)生长性能、免疫-抗氧化功能和血清抗菌性能的影响, 选用平均体重为(11.350.08)g的吉富罗非鱼960尾, 随机分为6组(每组4个重复, 每个重复40尾), 分别投喂基础饲料(对照组)和5种添加水平分别为18、36、54、72和90 mg/kg溶菌酶制品的试验饲料, 养殖周期为60d。结果表明: (1) 54 mg/kg溶菌酶添加组鱼的生长性能和饲料利用情况最优, 增重率和蛋白质效率均显著高于对照组, 饲料系数显著低于对照组(P0.05); 肝体比随溶菌酶添加水平的增加呈现下降趋势, 90 mg/kg添加组显著低于对照组(P0.05); 脾脏指数在36和54mg/kg添加组显著低于对照组(P0.05); 全鱼粗蛋白和粗灰分含量在54 mg/kg添加组均呈现较高水平, 显著高于对照组(P0.05)。(2)溶菌酶添加水平对罗非鱼的免疫-抗氧化能力产生影响, 54和72 mg/kg添加水平能显著提高鱼体血清和肝脏的超氧化物歧化酶、过氧化氢酶活性, 降低丙二醛含量(P0.05); 肝脏溶菌酶活性在54和72 mg/kg添加组均显著高于对照组(P0.05), 而血清溶菌酶活性随溶菌酶添加水平的增加呈现下降趋势(L90组除外), 显著低于对照组(P0.05)。(3)血清抗菌试验显示, 54和72 mg/kg溶菌酶添加组罗非鱼对大肠杆菌、金黄色葡萄球菌、嗜水气单胞菌和溶藻弧菌的抑制能力显著高于对照组(P0.05), 而对枯草芽孢杆菌的抵抗能力最低, 比对照组分别低34.71%和42.21% (P0.05)。结果表明, 在本试验条件下, 在吉富罗非鱼饲料中添加54 mg/kg溶菌酶制品可以改善其生长性能; 当添加水平为54和72 mg/kg时, 罗非鱼的免疫-抗氧化能力和血清抗菌性能均得到了显著提高。     

有机铬对奥尼罗非鱼生长和糖利用的影响

研究了葡萄糖饲料和淀粉饲料中添加 2mg/kg有机铬对初始体重约 1 4g的奥尼罗非鱼鱼种生长和糖利用的影响。经过 8周饲养 ,添加烟酸铬和吡啶羧酸铬的葡萄糖组罗非鱼特定生长率显著高于对照组 (P <0 0 5 )。饲料效率在添加烟酸铬和吡啶羧酸铬的葡萄糖组和淀粉组均显著高于对照组 (P <0 0 5 )。全鱼营养成分分析表明 ,添加吡啶羧酸铬、乙酸铬的葡萄糖组罗非鱼水分含量显著低于相应的淀粉组 ,而粗脂肪含量显著高于相应的淀粉组 (P <0 0 5 )。添加吡啶羧酸铬的葡萄糖组肝脏果糖二磷酸酶活力显著低于相应的淀粉组 ,而背肌磷酸果糖激酶活力显著高于相应的淀粉组 (P <0 0 5 )。结果说明 ,有机铬能显著促进罗非鱼对葡萄糖的利用 ;罗非鱼对葡萄糖和淀粉的利用能力无显著差异 ,但饲料糖源对体成分有显著影响     

亚硒酸钠、酵母硒和富硒螺旋藻对杂交鲟幼鱼生长、抗氧化能力及组织硒含量的影响

实验旨在研究饲料中不同类型和水平的硒源对杂交鲟(Acipenser baerii♂×Acipenser schrenckii♀)幼鱼生长、抗氧化能力及组织硒含量的影响。不同类型的硒源为亚硒酸钠、酵母硒和富硒螺旋藻,添加水平为0、0.4和1.2 mg/kg,制作对照饲料(C)、亚硒酸钠添加饲料(S1和S2)、酵母硒添加饲料(Y1和Y2)和富硒螺旋藻添加饲料(P1和P2)。使用实验饲料饲喂初始体重为(7.82±0.12) g的杂交鲟幼鱼,养殖62d。结果表明,不同硒源和硒水平对杂交鲟幼鱼的特定生长率和饲料效率无显著影响(P>0.05)。高水平亚硒酸钠显著提高了全鱼和肝脏硒含量(P<0.05),但对肌肉和脊椎骨硒含量无显著影响(P>0.05)。高水平酵母硒和富硒藻螺旋添加组杂交鲟幼鱼的全鱼、肝脏、肌肉及脊椎骨硒含量均显著高于对照组(P<0.05)。酵母硒添加组的血浆总蛋白(TP)和总胆固醇(TC)含量均显著高于对照组(P<0.05)。同时,高水平硒添加组杂交鲟幼鱼的血浆谷胱甘肽过氧化物酶(GSH-Px)活性显著高于对照组和低水平硒添加组(P<0.05)。亚...     

饲喂不同浓度黄曲霉毒素B1饲料对草鱼幼鱼生长和毒素积累的影响

以含不同浓度黄曲霉毒素B₁(AFB₁)(0、10、20、100、1000和5000 μg/kg饲料)的6种等氮等能(32.96%蛋白质, 14.55 kJ/g能量)配合饲料饲喂平均初始体质量为(2.90±0.16) g草鱼(Ctenopharyngodon idellus)幼鱼84d, 探讨AFB₁对草鱼幼鱼生长、肝胰脏和肾脏组织结构以及鱼体肌肉中的毒素积累的影响。实验分为6个实验组, 每组3个平行。结果表明, 在整个实验过程中各实验组幼鱼的行为均未表现出异常, 各组幼鱼的存活率、终末体重、摄食率、特定生长率、饲料效率、肝体比、脏体比均无显著差异。饲料AFB₁水平对草鱼幼鱼血清谷丙转氨酶(ALT)、谷草转氨酶(AST)、碱性磷酸酶(AKP)、超氧化物岐化酶(SOD)和谷胱甘肽过氧化物酶(GSH-Px)活性均无显著影响。各毒素组和对照组肝胰脏、肾脏组织学观察中未发现病理变化。摄食AFB₁≤1000 μg/kg的草鱼幼鱼肌肉中未检测出AFB₁残留, 仅在5000 μg/kg实验组中检测出肌肉中含有(1.21±0.18) μg/kg的AFB₁, 低于FDA食品安全限定标准。由此可见, 草鱼幼鱼至少可耐受AFB₁含量达5000 μg/kg饲料(实测值: 4979.2 μg/kg饲料) 84d。     

饲料中添加抗菌肽Surfactin对吉富罗非鱼肠道健康的影响

为研究饲料中添加抗菌肽Surfactin对吉富罗非鱼(GIFT, Oreochromis niloticus)肠道健康指标的影响, 实验将平均体重为(12.010.03) g/尾的320尾吉富罗非鱼, 随机分为4组, 每组4个重复, 每个重复20尾鱼, 分别投喂抗菌肽Surfactin添加水平为0(对照组)、50、100和200 mg/kg的试验饲料7周。结果显示: 与对照组相比, 吉富罗非鱼饲料中添加抗菌肽Surfactin可使肠道皱襞高度显著增加(P0.05), 肌层厚度无显著变化(P0.05); 大肠杆菌数量显著降低(P0.05), 乳酸杆菌数量显著增加(P0.05), 细菌总数无显著变化(P0.05); 显著提高肠道总抗氧化能力水平、谷胱甘肽过氧化物酶活性和超氧化物歧化酶活性(200 mg/kg抗菌肽添加组除外)(P0.05), 显著降低肠道丙二醛水平(P0.05), 对过氧化氢酶活性无显著影响(P0.05); 吉富罗非鱼肠道健康指标以50 mg/kg抗菌肽Surfactin添加组最佳。试验表明, 吉富罗非鱼饲料中适量添加抗菌肽Surfactin可增加肠道皱襞高度、调节肠道菌群和提高肠道抗氧化能力而改善肠道健康状态。     

饲料中添加胆汁酸对欧洲鳗鲡幼鱼肝脏脂肪代谢的影响

文章旨在研究饲料中添加胆汁酸对欧洲鳗鲡(Anguilla anguilla)幼鱼肝脏脂肪代谢的影响。将养殖欧洲鳗鲡幼鱼的9口水泥池[初始规格(141.5±1.9) g/尾;初始鱼重(682±23) kg/池]随机分为3个处理组,每组3口池,分别投喂基础饲料(对照组)、基础饲料添加500 mg/kg胆汁酸(BA1组)、基础饲料添加1000 mg/kg胆汁酸(BA2组)的饲料。实验期为15周。实验结果表明, BA组比对照组欧洲鳗鲡幼鱼肝脏组织中脂肪空泡数量明显减少,肝脏粗脂肪水平显著降低(P<0.05)。BA组欧洲鳗鲡幼鱼肝脏脂肪酸合成酶水平显著降低(P<0.05),仅BA1组乙酰辅酶A羧化酶水平显著降低(P<0.05), BA组肝脂酶、脂蛋白酯酶和总脂酶活性均显著升高(P<0.05); BA组间上述酶活性或水平均无显著差异(P>0.05)。BA1组欧洲鳗鲡幼鱼肝脏磷脂酰胆碱和溶血磷脂酰胆碱水平上调,主要是甘油磷脂代谢和甘油酯代谢增强。由此可见,欧洲鳗鲡幼鱼饲料中添加胆汁酸可通过降低脂肪合成有关酶水平及增加脂肪分解有关酶活性,主要增强甘油磷脂代谢和甘油酯代谢,...     

美洲鳗鲡幼鱼饲料中鱼油的适宜添加水平研究

为研究饲料中鱼油添加水平对美洲鳗鲡(Anguilla rostrata)幼鱼生长性能、消化酶、体成分及肝脏脂肪代谢的影响, 以确定美洲鳗鲡幼鱼饲料中鱼油的适宜添加水平, 选用初始体重(8.34±0.12) g的美洲鳗鲡幼鱼800尾, 随机分成5组, 每组4个重复, 每个重复40尾; 分别投喂添加0(对照组)、3%(FO3组)、6%(FO6组)、9%(FO9组)和12%(FO12组)鱼油的试验饲料, 试验期56d。结果表明, 饲料中添加鱼油显著影响美洲鳗鲡幼鱼生长性能, FO6组美洲鳗鲡幼鱼的增重率、投饵率和饲料效率显著高于其他处理组(P<0.05)。与对照组相比, 鱼油添加组美洲鳗鲡幼鱼肠道脂肪酶活性显著提高(P<0.05), 蛋白酶和淀粉酶活性显著降低(P<0.05); FO6组、FO9组和FO12组全鱼粗脂肪含量显著提高(P<0.05), 全鱼粗蛋白质含量在FO12组显著降低(P<0.05), 全鱼水分和灰分含量无显著变化(P>0.05); FO9组和FO12组脂肪酸合成酶活性显著降低(P<0.05), FO12组脂蛋白酯酶和肝脂酶活性显著升高(P<0.05)。综上, 饲料中添加适宜鱼油水平可以提高美洲鳗鲡幼鱼的生长性能, 调节肠道脂肪酶活性、全鱼粗脂肪含量和肝脏脂肪代谢酶水平或活性; 美洲鳗鲡幼鱼获得最佳增重率和饲料效率时, 饲料中鱼油添加水平推荐为6.43%—6.78%。     

荚膜甲基球菌蛋白替代鱼粉对卵形鲳鲹生长和抗氧化能力的影响

实验旨在研究荚膜甲基球菌(Methylococcus capsulatus, Bath)蛋白(MBM,斐康^?蛋白)替代鱼粉对卵形鲳鲹生长性能和抗氧化能力的影响。MBM添加量分别为0、3.5%、7%和10.5%,替代基础饲料中鱼粉(含量35%)0、10%、20%和30%,制得4组等氮等脂饲料,即MBM0、MBM10、MBM20和MBM30组,饲喂卵形鲳鲹幼鱼[初始均重(34.88±1.13) g]56d。实验结果显示,随着饲料中MBM含量的升高,各组间的末均重、增重率、特定生长率、存活率、肝体比、脏体比和饲料系数均无显著性差异(P>0.05)。MBM30组肥满度显著高于MBM0组(P<0.05)。各组全鱼粗蛋白含量无显著差异(P>0.05), MBM20组全鱼粗脂肪含量显著高于MBM0组和MBM10组(P<0.05)。MBM20组和MBM30组背肌粗脂肪含量显著高于MBM0组(P<0.05),背肌粗脂肪与MBM替代鱼粉的比例呈显著正相关关系(P<0.05)。MBM20和MBM30组血清甘油三酯显著低于MBM0组(P<0.05...     

饲料中黄曲霉毒素B1对克氏原螯虾幼虾生长、饲料利用和肝胰腺组织结构的影响

以含不同浓度黄曲霉毒素B₁(AFB₁)(0、10、100和1000μg/kg饲料)的4种饲料饲喂初始均重为(0.382±0.005) g的克氏原螯虾(Procambarus clarkii)幼虾42d,探讨AFB₁对克氏原螯虾幼虾生长性能、饲料效率和肝胰腺组织结构的影响。结果显示, 100和1000μg/kg毒素组幼虾的存活率、摄食率、终末体重、特定生长率和饲料效率均显著低于对照组, 10μg/kg毒素组与对照组无显著差异。10μg/kg毒素组幼虾肝胰腺碱性磷酸酶(AKP)、谷丙转氨酶(ALT)、谷草转氨酶(AST)、过氧化氢酶(CAT)、谷胱甘肽过氧化物酶(GSH-Px)、谷胱甘肽转移酶(GST)活性和丙二醛(MDA)含量均与对照组无显著差异,超氧化物歧化酶(SOD)活性显著低于对照组。饲料AFB₁含量≥100μg/kg时显著影响了克氏原螯虾幼虾上述肝胰腺酶的活性。10μg/kg毒素组肝胰腺组织结构发生轻微变化, 100和1000μg/kg毒素组幼虾的肝胰腺表现出严重病变, R细胞数量减少而B细胞...     

Comparison of metabolic rates and feed nutrient digestibility in conventional, genetically improved (GIFT) and genetically male (GMNT) Nile tilapia, Oreochromis niloticus (L.)

Various aspects of energy metabolism and feed digestibility were evaluated in two reportedly improved strains of Nile tilapia (Oreochromis niloticus) namely GIFT (genetically improved farmed tilapia) and GMNT (genetically male Nile tilapia) and compared with those of CNT (conventional Nile tilapia). Fish were stocked individually in a computer-controlled respirometer system at 27+/-0.1 degrees C for 10 weeks. Metabolic rates were measured at three different feeding levels: starved, maintenance (3.0 g kg(-0.8) day(-1)) and growth (7.5 g kg(-0.8) day(-1)) using a fishmeal based feed containing TiO2 marker (41% crude protein, 9% crude lipid and 19 kJ (g DM)(-1) gross energy). The standard metabolic rate (SMR), measured at the beginning of the experiment (45.4+/-4.6, 52.4+/-7.7 and 46.8+/-4.6 mg O2 kg(-0.8) h(-1) respectively for GIFT, GMNT and CNT), did not differ significantly between the groups (p<0.05). Similarly, non-significant differences were also observed in the routine metabolic rates under starved, maintenance and growth conditions but the variability was higher in the case of GMNT and CNT than in GIFT. The latter group showed a significantly lower active metabolic rate (145 mg O2 kg(-0.8) h(-1)) compared to GMNT and CNT (232 and 253 mg O2 kg(-0.8) h(-1), respectively) at maintenance feeding level. The specific dynamic action (% offered feed energy) showed no significant differences among the groups. Digestibility coefficients of feed dry matter, protein, lipid and energy for the three tilapia groups also did not differ significantly. Therefore, we concluded that the genetic improvement or modification in the GIFT or GMNT might not upgrade the inherent physiological potential compared to CNT as far as energy metabolism and digestion efficiencies are concerned.     

Effect of coenzyme Q10 on catalase activity and other antioxidant parameters in streptozotocin-induced diabetic rats

Although coenzyme Q10 (CoQ10) is a component of the oxidative phosphorylation process in mitochondria that converts the energy in carbohydrates and fatty acids into ATP to drive cellular machinery and synthesis, its effect in type I diabetes is not clear. We have studied the effect of 4 wk of treatment with CoQ10 (10 mg/kg, ip, daily) in streptozotocin (STZ)-induced (40 mg/kg, iv in adult rats) type I diabetes rat models. Treatment with CoQ10 produced a significant decrease in elevated levels of glucose, cholesterol, triglycerides, very-low-density lipoprotein, lowdensity lipoprotein, and atherogenic index and increased high-density lipoprotein cholesterol levels in diabetic rats. CoQ10 treatment significantly decreased the area under the curve over 120 min for glucose in diabetic rats, without affecting serum insulin levels and the area under the curve over 120 min for insulin in diabetic rats. CoQ10 treatment also reduced lipid peroxidation and increased antioxidant parameters like superoxide dismutase, catalase, and glutathione in the liver homogenates of diabetic rats. CoQ10 also lowered the elevated blood pressure in diabetic rats. In conclusion, CoQ10 treatment significantly improved deranged carbohydrate and lipid metabolism of experimental chemically induced diabetes in rats. The mechanism of its beneficial effect appears to be its antioxidant property.     

饲料中添加谷胱甘肽对黄颡鱼幼鱼组织谷胱甘肽含量、免疫及抗氧化性能的影响

研究旨在探讨饲料中添加还原型谷胱甘肽(Glutathione, GSH)对黄颡鱼幼鱼(Pelteobagrus fulvidraco)组织谷胱甘肽含量、免疫及抗氧化性能的影响。选用初始体重为(1.32±0.01) g的黄颡鱼800尾, 随机分为5组, 每组4个重复, 每个重复40 尾鱼, 分别投喂基础饲料和添加100、300、500和700 mg/kg GSH的试验饲料, 饲养56d后采样分析, 并采用氯化铵进行96h氨氮应激试验。结果表明: 除100 mg/kg组外, 饲料中添加GSH显著提高黄颡鱼肝脏、血清GSH含量(P<0.05), 当GSH添加量≥300 mg/kg时, 肝脏和血清GSH含量均呈现稳定状态。随着饲料中谷胱甘肽水平的增加, 血清免疫和肝脏抗氧化指标均呈现先升高后降低的趋势, 其中300和500 mg/kg组溶菌酶与碱性磷酸酶活性、300 mg/kg组免疫球蛋白M与补体4含量、500 mg/kg组酸性磷酸酶活性与对照组相比显著升高(P<0.05)。与对照组和700 mg/kg组相比, 300 mg/kg组肝脏超氧化物歧化酶、过氧化氢酶、谷胱甘肽过氧化酶活性和总抗氧化能力与血清超氧化物歧化酶、谷胱甘肽过氧化酶活性均显著高升高(P<0.05); 且300 mg/kg组血清丙二醛含量显著降低(P<0.05)。氨氮应激96h时, 与对照组相比, 300 mg/kg组肝脏和血清超氧化物歧化酶、过氧化氢酶、谷胱甘肽过氧化酶活性力均显著升高(P<0.05), 且300 mg/kg组血清丙二醛含量显著降低(P<0.05)。由此可见, 饲料中添加谷胱甘肽能提高黄颡鱼幼鱼组织谷胱甘肽含量、免疫及抗氧化性能, 其中以300—500 mg/kg为宜。     

Suppressive effect of coenzyme Q10 on phospholipase A2 activation in cardiac cells after prolonged swimming.

Phospholipase A2 (PLA2) activity is elevated in cardiac microsomal fractions and phospholipids (PL) are much reduced in both the cardiac mitochondria and microsomal fractions from rats subjected to prolonged swimming. Preadministration of coenzyme Q10 (CoQ10 i.v. 30 mg/kg) significantly suppressed these changes. Two groups of 8-week-old male Wistar rats were trained to swim, receiving 30 min of training for 4 days. On the fifth day they were given an intravenous injection of either 30 mg/kg CoQ10 in saline or 1 ml saline. Thirty minutes later they began to swim for 3 hours carrying a weight representing 3% of body weight. On completion of the swim they were sacrified by instantaneous decapitation, and cardiac mitochondria were isolated. Mitochondria were also prepared from saline injected, unexercised control rats. Phosphatidylethanolamine (PE) and phosphatidylcholine (PC) concentrations were measured with HPLC and PLA2 activity was assayed fluorometrically. The mitochondrial concentrations (means +/- SEM, n = 6) of PE and PC were respectively 126 +/- 22 and 140 +/- 22 nmol/mg protein in the exercise-CoQ10 group against 66 +/- 4 and 50 +/- 10 nmol/mg protein in the exercise-saline group. The specific PLA2 activities (expressed as nmol degraded dipyrene phosphorylethanolamine substrate/hr/mg protein) in the microsomes was 0.20 +/- 0.02 in the exercise-CoQ10 group against 0.30 +/- 0.02 in the exercise-saline group. These results suggest CoQ10 has a protective effect against an excessive reduction in mitochondrial membrane phospholipids during prolonged exercise.     

甘露寡糖对异育银鲫生长性能、免疫及HSP70基因表达的影响

为探讨甘露寡糖(MOS)对异育银鲫生长、免疫、肠道组织结构及抗病力的影响,试验选取360尾异育银鲫[初均重(16.19±0.03)g],随机分成5组、每组3个重复,在日粮中添加不同浓度甘露寡糖(0、60、120、240、480 mg/kg),连续投喂80d,并于第80天时进行嗜水气单胞菌感染,测定异育银鲫生长、免疫、肠道结构等指标及异育银鲫抗嗜水气单胞菌感染的能力。试验结果表明,无论投喂50d,还是80d,甘露寡糖对鱼体的生长指标(特定生长率、增重率、蛋白质效率、饵料系数)均没有显著影响(P>0.05);投喂50d,与对照组比,甘露寡糖能显著提高血清球蛋白浓度(P<0.05);投喂80d后,与对照组比,240、480 mg/kg甘露寡糖组能显著提高碱性磷酸酶活性,甘露寡糖组能显著提高血清球蛋白浓度(P<0.05),480 mg/kg甘露寡糖组能显著提高血清总抗氧化能力,120、240 mg/kg甘露寡糖组能显著提高肠褶皱襞长(P<0.05),对皱襞间质宽、黏膜下层宽没有显著影响(P>0.05),肌层宽随着MOS的添加有增加趋势(P>0.05);嗜水气单胞菌感染后,与对照组比,240、480 mg/kg甘露寡糖组成活率提高了22.6%,免疫保护率达45.4%。日粮中添加甘露寡糖组对鱼体肝脏HSP70基因表达没有显著影响(P>0.05)。因此,添加240、480 mg/kg甘露寡糖能提高鱼体的免疫能力,增强鱼体抗病原菌感染能力。     

Life-long supplementation with a low dosage of coenzyme Q10 in the rat: effects on antioxidant status and DNA damage

Life-long low-dosage supplementation of coenzyme Q(10) (CoQ(10)) is studied in relation to the antioxidant status and DNA damage. Thirty-two male rats were assigned into two experimental groups differing in the supplementation or not with 0.7 mg/kg/day of CoQ(10). Eight rats per group were killed at 6 and 24 months. Plasma retinol, alpha-tocopherol, coenzyme Q, total antioxidant capacity and fatty acids were analysed. DNA strand breaks were studied in peripheral blood lymphocytes. Aging and supplementation led to significantly higher values for CoQ homologues, retinol and alpha-tocopherol. No difference in total antioxidant capacity was detected at 6 months but significantly lower values were found in aged control animals. Similar DNA strand breaks levels were found at 6 months. Aging led to significantly higher DNA strand breaks levels in both groups but animals supplemented with CoQ(10) led to a significantly lower increase in that marker. Aged rats showed significantly higher polyunsaturated fatty acids. This study demonstrates that lifelong intake of a low dosage of CoQ(10) enhances plasma levels of CoQ(9), CoQ(10), alpha-tocopherol and retinol. In addition, CoQ(10) supplementation attenuates the age-related fall in total antioxidant capacity of plasma and the increase in DNA damage in peripheral blood lymphocytes.     

Coenzyme Q10 protect against ischemia/reperfusion induced biochemical and functional changes in rabbit urinary bladder

Purpose Ischemia, reperfusion, and free radical generation have been recently implicated in the progressive bladder dysfunction. Coenzyme Q10 (CoQ10) is a pro-vitamin like substance that appears to be efficient for treatment of neurodegenerative disorders and ischemic heart disease. Our goal was to investigate the potential protective effect of CoQ10 in a rabbit model of in vivo bilateral ischemia and ischemia/reperfusion (I/R). Material and Methods Six groups of four male New Zealand White rabbits each were treated with CoQ10 (3 mg/kg body weight/day—dissolved in peanut oil) (groups 1–3) or vehicle (peanut oil) (groups 4–6). Groups 1 and 4 (ischemia-alone groups) had clamped bilateral vesical arteries for 2 h; in groups 2 and 5 (I/R groups), bilateral ischemia was similarly induced and the rabbits were allowed to recover for 2 weeks. Groups 3 and 6 were controls (shams) and were exposed to sham surgery. The effects on contractile responses to various stimulations and biochemical studies such as citrate synthase (CS), choline acetyltransferase (ChAT), superoxide dismutase (SOD), and catalase (CAT) were evaluated. The protein peroxidation indicator, carbonyl group, and nitrotyrosine contents were analyzed by Western blotting. Results Ischemia resulted in significant reductions in the contractile responses to all forms of stimulation in vehicle-fed rabbits, whereas there were no reductions in CoQ10-treated rabbits. Contractile responses were significantly reduced in vehicle-treated I/R groups, but significantly improved in CoQ10-treated rabbits. Protein carbonylation and nitration increased significantly in ischemia-alone and I/R bladders; CoQ10 treatment significantly attenuated protein carbonylation and nitration. CoQ10 up-regulated SOD and CAT activities in control animals; the few differences in CoQ10-treated animal in SOD and CAT after ischemia and in general increase CAT activities following I/R. Conclusions CoQ10 supplementation provides bladder protection against I/R injury. This protection effect improves mitochondrial function during I/R by repleting mitochondrial CoQ10 stores and potentiating their antioxidant properties.     

维生素E对中华鳖幼鳖生长、肝脏维生素E以及血清皮质醇含量的影响

为探讨维生素E(VE)对中华鳖(Pelodiscus sinensis)幼鳖的生长、肝脏VE和血清皮质醇的影响，通过特定生长率、高压液相色谱法和放免法，我们测定了中华鳖幼鳖的生长、肝脏VE和血清皮质醇含量。发现VE添加量为1000和5000mg／kg的两组，能明显降低中华鳖幼鳖的生长。维生素E添加量为500、1000和5000mg／kg的三组，肝脏维生素E含量明显高于对照组，VE添加量在0—1000mg／kg的范围时，肝脏VE的含量随着饲料中VE含量的增加呈指数式增加，并且在VE添加量为5000kg／kg的一组基本达到饱和。维生素E添加量为0和50mg／kg的2组，其血清皮质醇的平均值明显高于维生素E添加量为250、500、1000和5000mg／kg的4组的平均值。上述结果表明：高剂量的VE降低了中华鳖幼鳖的生长和血清皮质醇的含量；在一定剂量范围内，肝脏VE随着饲料中VE含量的增加而升高。